期刊文献+

直肠癌周围黏膜下注射微粒子碳在TME术中的应用

Clinical application of submucosal injection of particulate carbon around the rectal cancer lesions in total mesorectal excision
下载PDF
导出
摘要 目的:探讨微粒子碳在直肠癌全直肠系膜切除术(TME)中的应用价值.方法:对45例直肠癌患者术前3d在直肠镜癌周黏膜下注射微粒子碳,行全直肠系膜切除术.并与常规TME手术组进行比较.所有切除淋巴结行RT-PCR法检测MMP-7mRNA的表达以确定此淋巴结有无转移.结果:实验组共清除淋巴结1056枚,平均23.5枚.对照组清除淋巴结723枚,平均16.1枚,两组比较有统计学意义(t=7.3733,P<0.05).实验组清除转移淋巴结403枚,平均9.0枚.对照组281枚,平均6.2枚,差别具有统计学意义(t=5.4235,P<0.05).实验组黑染淋巴结共680枚,其中转移淋巴结322枚,两者具有线性相关关系(r=0.3468,P<0.05).结论:黏膜下注射微粒子碳应用于直肠癌TME术可增加术中转移淋巴结的清除.直肠癌淋巴结墨染与转移有关. AIM: To evaluate the application value of particulate carbon in total mesorectal excision.. METHODS: Particulate carbon was submucosally injected around the rectal cancer lesions under rectoscope in 45 patients 3 d before total mesorectal excision. The expression of matrix metaUoproteinase-7 (MMP-7) mRNA was detected by reverse transcription-polymerase chain reaction (RT-PCR) to ascertain the lymph node metastasis. RESULTS: The labelled lymph nodes were easily identified during the operation. The average numbers of eliminated lymph nodes and metastatic lymph nodes in the labelled group were larger than those in the controls (23.5 vs 16.1, t = 7.3733, P 〈 0.05; 9.0 vs 6.2, t = 5.4235, P 〈 0.05). In the labelled group, there were 680 labelled lymph nodes, of which 322 were metastatic ones. The numbers of labelled and metastatic lymph nodes were linearly correlated with each other (r = 0.3468, P 〈 0.05). CONCLUSION: Submucosal injection of particulate carbon can help to clean metastatic lymph nodes in total mesorectal excision. The number of labelled lymph nodes is correlated with that of metastatic lymph nodes.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第26期2652-2654,共3页 World Chinese Journal of Digestology
关键词 直肠癌 微粒子碳 淋巴结转移 Rectal cancer Particulate carbon Lym-phatic metastasis
  • 相关文献

参考文献11

  • 1Minton JP,Hoehn JL,Gerber DM,Horsley JS,Connolly DP,Salwan F,Fletcher WS,Cruz AB Jr,Gatchell FG,Oviedo M.Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study.Cancer 1985; 55:1284-1290
  • 2Dixon AR,Maxwell WA,Holmes JT.Carcinoma of the rectum:a 10-year experience.Br J Surg 1991; 78:308-311
  • 3Havenga K,Enker WE,Norstein J,Moriya Y,Heald RJ,van Houwelingen HC,van de Velde CJ.Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer:an international analysis of 1411 patients.Eur J Surg Oncol 1999; 25:368-374
  • 4Sawai K,Takahashi T,Suzuki H.New trends in surgery for gastric cancer in Japan.J Surg Oncol1994; 56:221-226
  • 5Heald RJ.Total mesorectal exsicion (TME).Acta Chir Iugosl 2000; 47:17-18
  • 6Roselli M,Buonomo O,Piazza A,Guadagni F,Vecchione A,Brunetti E,Cipriani C,Amadei G,Nieroda C,Greiner JW,Casciani CU.Novel clinical approaches in monoclonal antibodybased management in colorectal cancer patients:radioimmunoguided surgery and antigen augmentation.Semin Surg Oncol 1998; 15:254-262
  • 7Hladik P,Vizda J,Bedrna J,Simkovic D,Strnad L,Smejkal K,Voboril Z.Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma.Colorectal Dis2001; 3:380-386
  • 8Gu J,Zhao J,Li Z,Yang Z,Zhang J,Gao Z,Wang Y,Xu G.Clinical application of radioimmunoguided surgery in colorectal cancer using 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally.Dis Colon Rectum 2003; 46:1659-1666
  • 9万远廉,潘义生,刘玉村,郭源,魏群.RT-PCR方法诊断大肠癌淋巴结微转移[J].中国实用外科杂志,2000,20(1):47-48. 被引量:19
  • 10Roeb E,Arndt M,Jansen B,Schumpelick V,Matern S.Simultaneous determination of matrix metalloproteinase (MMP)-7,MMP-1,-3,and -13gene expression by multiplex PCR in colorectal carcinomas.Int J Colorectal Dis 2004; 19:518-524

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部